BMS-813160 Uses, Dosage, Side Effects and more

BMS-813160 is under investigation in clinical trial NCT03496662 (BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)).

Trade Name BMS-813160
Generic BMS-813160
Type
Formula C25H40N8O2
Weight Average: 484.649
Monoisotopic: 484.32742256
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share